CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,702 | -25.0% | 44,730 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $76,936 | +113041.2% | 44,730 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $68 | -73.9% | 44,730 | -72.6% | 0.00% | -80.0% |
| Q4 2022 | $261 | -99.9% | 162,997 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $236,000 | -20.8% | 162,997 | 0.0% | 0.01% | -37.5% |
| Q2 2022 | $298,000 | -31.5% | 162,997 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $435,000 | +27.9% | 162,997 | +214.2% | 0.01% | 0.0% |
| Q4 2020 | $340,000 | -48.3% | 51,873 | -47.6% | 0.01% | -65.5% |
| Q3 2020 | $658,000 | +221.0% | 98,941 | +302.7% | 0.03% | +190.0% |
| Q2 2020 | $205,000 | -38.3% | 24,571 | -43.2% | 0.01% | -66.7% |
| Q1 2020 | $332,000 | -49.3% | 43,291 | -45.0% | 0.03% | +3.4% |
| Q4 2019 | $655,000 | – | 78,779 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |